ESR1 and cancer: Moreover, the enrichment of APOBEC3 mutagenesis in MBC compared with primary disease has further raised the question of whether APOBEC3 activity is ‘acquired,’ such as ESR1 mutations, or is intrinsic to the evolvable nature of these cancers.